Trial · NCT06270966
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Side effects; Dropout rates; Proportion of recruited participants among those considered eligible | T0 (0 weeks); T1 (12 weeks) | Feasibility will be assessed based on tolerability, including dropout rates and acceptability, which considers the proportion of recruited participants among those considered eligible and side effects. |
| Secondary | Short Form Health Survey, 12 items (SF-12) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on quality of life, 12 items |
| Secondary | Brief Social Rhythms Scale (BSRS) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on biological and social rhythms, 10 items |
| Secondary | Patient Health Questionnaire (PHQ-9) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on depressive symptoms, 9 Items |
| Secondary | Generalized Anxiety Disorder-7 item (GAD-7) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on anxiety, 7 items |
| Secondary | Addenbrooke's Cognitive Examination (ACE-R) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on general cognitive functions, the neuropsychological tests is used to identify cognitive impairment in conditions such as dementia. |
| Secondary | Matrix test | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on attention |
| Secondary | Rey's Word Test | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on memory |
| Secondary | Trail Making Test (TMT) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on executive function |
| Secondary | Digit Span | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on memory |
| Secondary | Stroop Test | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on executive function |
| Secondary | Frontal Assessment Battery (FAB) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on executive function |
| Secondary | Cognitive Estimates Test (CET) | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on executive function |
| Secondary | Rey Figure Test | T0 (0 weeks); T1 (12 weeks); T2 (36 weeks); (72 weeks) | Preliminary measures of effectiveness on visual spatial function |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06270966/registered